ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

How to Safely Re-engage Allergy Immunotherapy Patients after Coronavirus Shutdown

June 15, 2020

  • Tweet
  • Email
Print-Friendly Version

As with the rest of medicine, the impact of COVID-19 on otolaryngology has been unprecedented, and there are limited scientific data and expert opinions on how to return to practice. Much as we all had to think through patient and practice impact during the shutdown and circumvent negative outcomes when possible, some of those same impact and outcome issues are still at play as physicians consider new protocols.

You Might Also Like

No related posts.

Explore This Issue
June 2020

While the questions are many—Which services to start with? Which patients? Which payers? Which procedures? Which site of service?—otolaryngology practices that include allergic disorder management are definitely aware of the benefits of a steady patient population as they start to rebuild. However, these practices need to consider how best to re-engage their allergy immunotherapy patients.

As otolaryngology practices across the U.S. start to shift from acute and emergent-only to re-opening for elective procedures and full clinics, there are several new issues to consider. Recently, the American Academy of Otolaryngic Allergy (AAOA) leadership drafted some guidance on resuming immunotherapy. The AAOA sought to incorporate practical clinical considerations, including patient and medical staff protection.

Protecting Patients

Restarting subcutaneous immunotherapy (SCIT) after a prolonged absence can result in a serious systemic adverse event, so safety is paramount when re-starting injections. Dosing can be reduced to allow for more gradual re-introduction. A key factor in determining how far back to reduce the dose is the time since the last injection. There are limited data on an exact dosing scheme. In its guidance, AAOA’s example (see below) is in line with expert opinion.

Where a patient is in SCIT also plays a role in determining the dose. Patients in the maintenance phase are generally able to tolerate a higher dosing schedule than those in the escalation phase. 

Clinical features should also be examined for each patient—allergic disease severity, prior systemic reactions, time of year for pollen allergies, health status, including medications, and asthma severity and control all need to be considered. Patients who are at increased risk of an adverse reaction due to any of these factors may need a dosing decrease at the first injection beyond what the example describes. The escalation schedule will similarly depend on individual factors and prior injection tolerance. Vial testing prior to the first injection can also provide a measure of safety to determine an individual patient’s reaction and tolerability before proceeding.

Restarting subcutaneous immunotherapy after a prolonged absence can result in a serious systemic adverse event, so safety is paramount when re-starting injections. Dosing can be reduced to allow for more gradual re-introduction.

In addition to SCIT, allergy patients may benefit from corticosteroids, and current recommendations advocate for continued use of inhaled steroids and nasal steroid sprays to maintain a healthy airway and avoid the need for emergency care. Systemic corticosteroids have a special consideration in the era of COVID-19 infection, however—their use in patients with active COVID-19 infections has been shown to worsen the infection in its early phases and should be avoided except in cases of acute respiratory distress syndrome (ARDS). Corticosteroids can still be used in the COVID-19 era. The decision for the use of short bursts of systemic corticosteroids should be made using the shared-decision model, informing patients of the risks of potentially worsening their COVID-19 infection while helping them avoid an emergent case where there could be exposure to COVID-19-positive providers and patients.

Pages: 1 2 | Single Page

Filed Under: Features Tagged With: coronavirus, COVID19, immunotherapy, patient care, patient safetyIssue: June 2020

You Might Also Like:

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Some Studies Predict a Shortage of Otolaryngologists. Do the Numbers Support Them?
    • Vertigo in the Elderly: What Does It Mean?
    • Complications for When Physicians Change a Maiden Name
    • Neurogenic Cough Is Often a Diagnosis of Exclusion
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • Tympanoplasty Tips: Otology Experts Give Advice on the Procedure
    • How Treatment for Obstructive Sleep Apnea (OSA) Is Evolving to Give Patients a Better Night’s Sleep
    • Vestibular Schwannoma Position Relative to Internal Auditory Canal Helps Predict Postoperative Facial Function
    • Vocal Fold Lipoaugmentation Provides Long-Term Voice Improvements for Glottal Insufficiency
    • Upper Lateral Cartilage Mucosal Flap Enables the Successful Closure of Larger Septal Perforations

Polls

Do you think there will be a shortage of otolaryngologists in the next five to 10 years?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2022 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.